Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Leah F, Moriarty"'
Autor:
Catherine Bakari, Celine I. Mandara, Rashid A. Madebe, Misago D. Seth, Billy Ngasala, Erasmus Kamugisha, Maimuna Ahmed, Filbert Francis, Samwel Bushukatale, Mercy Chiduo, Twilumba Makene, Abdunoor M. Kabanywanyi, Muhidin K. Mahende, Reginald A. Kavishe, Florida Muro, Sigsbert Mkude, Renata Mandike, Fabrizio Molteni, Frank Chacky, Dunstan R. Bishanga, Ritha J. A. Njau, Marian Warsame, Bilali Kabula, Ssanyu S. Nyinondi, Naomi W. Lucchi, Eldin Talundzic, Meera Venkatesan, Leah F. Moriarty, Naomi Serbantez, Chonge Kitojo, Erik J. Reaves, Eric S. Halsey, Ally Mohamed, Venkatachalam Udhayakumar, Deus S. Ishengoma
Publikováno v:
Malaria Journal, Vol 23, Iss 1, Pp 1-11 (2024)
Abstract Background Therapeutic efficacy studies (TESs) and detection of molecular markers of drug resistance are recommended by the World Health Organization (WHO) to monitor the efficacy of artemisinin-based combination therapy (ACT). This study as
Externí odkaz:
https://doaj.org/article/bbdfbdb13b094de59208ee4c4414aa68
Autor:
Ashenafi Assefa, Hussein Mohammed, Anjoli Anand, Adugna Abera, Heven Sime, Anna A. Minta, Mekonnen Tadesse, Yehualashet Tadesse, Samuel Girma, Worku Bekele, Kebede Etana, Bereket Hailegiorgis Alemayehu, Hiwot Teka, Dereje Dilu, Mebrahtom Haile, Hiwot Solomon, Leah F. Moriarty, Zhiyong Zhou, Samaly Souza Svigel, Bryan Ezema, Geremew Tasew, Adugna Woyessa, Jimee Hwang, Matthew Murphy
Publikováno v:
Malaria Journal, Vol 21, Iss 1, Pp 1-13 (2022)
Abstract Background Routine monitoring of anti-malarial drugs is recommended for early detection of drug resistance and to inform national malaria treatment guidelines. In Ethiopia, the national treatment guidelines employ a species-specific approach
Externí odkaz:
https://doaj.org/article/6397b4994453409a890de60e86c6ab87
Autor:
Alicia Dunajcik, Kambria Haire, Jennifer D. Thomas, Leah F. Moriarty, Yuri Springer, Julie M. Villanueva, Adam MacNeil, Benjamin Silk, Jeffrey B. Nemhauser, Ramona Byrkit, Melanie Taylor, Krista Queen, Suxiang Tong, Justin Lee, Dhwani Batra, Clinton Paden, Tiffany Henderson, Audrey Kunkes, Mojisola Ojo, Melanie Firestone, Lindsey Martin Webb, Melissa Freeland, Catherine M. Brown, Thelonious Williams, Krisandra Allen, Judy Kauerauf, Erica Wilson, Seema Jain, Eric McDonald, Elana Silver, Sarah Stous, Debra Wadford, Rachel Radcliffe, Chandra Marriott, Jennifer P. Owes, Stephen M. Bart, Lynn E. Sosa, Kelly Oakeson, Natalie Wodniak, Julia Shaffner, Quanta Brown, Ryan Westergaard, Andrea Salinas, Sara Hallyburton, Yasmin Ogale, Tabatha Offutt-Powell, Kimberly Bonner, Sheri Tubach, Clay Van Houten, Victoria Hughes, Valerie Reeb, Chris Galeazzi, Shreya Khuntia, Sasha McGee, Joseph T. Hicks, Dimple Dinesh Patel, Anna Krueger, Scott Hughes, Fabiana Jeanty, Jade C. Wang, Ellen H. Lee, Tracey Assanah-Deane, Megan Tompkins, Kendra Dougherty, Ozair Naqvi, Matthew Donahue, Justin Frederick, Baha Abdalhamid, Ann M. Powers, Mark Anderson
Publikováno v:
PLOS Global Public Health, Vol 3, Iss 3 (2023)
The first three SARS-CoV-2 phylogenetic lineages classified as variants of concern (VOCs) in the United States (U.S.) from December 15, 2020 to February 28, 2021, Alpha (B.1.1.7), Beta (B.1.351), and Gamma (P.1) lineages, were initially detected inte
Externí odkaz:
https://doaj.org/article/a3b2d47f68b44f798cbea60ad20ff66f
Autor:
Chris Ebong, Asadu Sserwanga, Jane Frances Namuganga, James Kapisi, Arthur Mpimbaza, Samuel Gonahasa, Victor Asua, Sam Gudoi, Ruth Kigozi, James Tibenderana, John Bosco Bwanika, Agaba Bosco, Denis Rubahika, Daniel Kyabayinze, Jimmy Opigo, Damian Rutazana, Gloria Sebikaari, Kassahun Belay, Mame Niang, Eric S. Halsey, Leah F. Moriarty, Naomi W. Lucchi, Samaly S. Svigel Souza, Sam L. Nsobya, Moses R. Kamya, Adoke Yeka
Publikováno v:
Malaria Journal, Vol 20, Iss 1, Pp 1-12 (2021)
Abstract Background In Uganda, artemether-lumefantrine (AL) is first-line therapy and dihydroartemisinin-piperaquine (DP) second-line therapy for the treatment of uncomplicated malaria. This study evaluated the efficacy and safety of AL and DP in the
Externí odkaz:
https://doaj.org/article/8528def3450848f184ccf4ee0df58e73
Autor:
Ashenaf Assefa, Hussein Mohammed, Anjoli Anand, Adugna Abera, Heven Sime, Anna A. Minta, Mekonnen Tadesse, Yehualashet Tadesse, Samuel Girma, Worku Bekele, Kebede Etana, Bereket Hailegiorgis Alemayehu, Hiwot Teka, Dereje Dilu, Mebrahtom Haile, Hiwot Solomon, Leah F. Moriarty, Zhiyong Zhou, Samaly Souza Svigel, Bryan Ezema, Geremew Tasew, Adugna Woyessa, Jimee Hwang, Matthew Murphy
Publikováno v:
Malaria Journal, Vol 22, Iss 1, Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/779a4ff13c034dd8bfb719f916f7e939
Autor:
Catherine M. Dentinger, Tovonahary Angelo Rakotomanga, Antsa Rakotondrandriana, Arinomenjanahary Rakotoarisoa, Marie Ange Rason, Leah F. Moriarty, Laura C. Steinhardt, Laurent Kapesa, Jocelyn Razafindrakoto, Samaly S. Svigel, Naomi W. Lucchi, Venkatachalam Udhayakumar, Eric S. Halsey, C. Arsène Ratsimbasoa
Publikováno v:
Malaria Journal, Vol 20, Iss 1, Pp 1-11 (2021)
Abstract Background Since 2005, artemisinin-based combination therapy (ACT) has been recommended to treat uncomplicated falciparum malaria in Madagascar. Artesunate-amodiaquine (ASAQ) and artemether-lumefantrine (AL) are the first- and second-line tr
Externí odkaz:
https://doaj.org/article/df32110b281d46a280c7dd012b62afec
Autor:
Abel Nhama, Lídia Nhamússua, Eusébio Macete, Quique Bassat, Crizolgo Salvador, Sónia Enosse, Baltazar Candrinho, Eva Carvalho, Arsénio Nhacolo, Arlindo Chidimatembue, Abuchahama Saifodine, Rose Zulliger, Naomi Lucchi, Samaly S. Svigel, Leah F. Moriarty, Eric S. Halsey, Alfredo Mayor, Pedro Aide
Publikováno v:
Malaria Journal, Vol 20, Iss 1, Pp 1-12 (2021)
Abstract Background Artemisinin-based combination therapy (ACT) has been the recommended first-line treatment for uncomplicated malaria in Mozambique since 2006, with artemether–lumefantrine (AL) and amodiaquine–artesunate (AS–AQ) as the first
Externí odkaz:
https://doaj.org/article/d7fcf41e715d4331a632b40ce0e89937
Autor:
Sarah E. Schmedes, Dhruviben Patel, Simran Dhal, Julia Kelley, Samaly S. Svigel, Pedro Rafael Dimbu, Adicatou-Laï Adeothy, Gauthier Mesia Kahunu, Papy Mandoko Nkoli, Abdoul Habib Beavogui, Simon Kariuki, Don P. Mathanga, Ousmane Koita, Deus Ishengoma, Ally Mohamad, Moonga Hawela, Leah F. Moriarty, Aaron M. Samuels, Julie Gutman, Mateusz M. Plucinski, Venkatachalam Udhayakumar, Zhiyong Zhou, Naomi W. Lucchi, Meera Venkatesan, Eric S. Halsey, Eldin Talundzic
Publikováno v:
Emerging Infectious Diseases, Vol 27, Iss 7, Pp 1902-1908 (2021)
The spread of drug resistance to antimalarial treatments poses a serious public health risk globally. To combat this risk, molecular surveillance of drug resistance is imperative. We report the prevalence of mutations in the Plasmodium falciparum kel
Externí odkaz:
https://doaj.org/article/4ca4aece9c33406d8814c20224b667b5
Autor:
Youssouf Diarra, Oumar Koné, Lansana Sangaré, Lassina Doumbia, Dade Bouye Ben Haidara, Mouctar Diallo, Ababacar Maiga, Hamadoun A. Sango, Halidou Sidibé, Jules Mihigo, Douglas Nace, Dragan Ljolje, Eldin Talundzic, Venkatachalam Udhayakumar, Erin Eckert, Celia J. Woodfill, Leah F. Moriarty, Pharath Lim, Donald J. Krogstad, Eric S. Halsey, Naomi W. Lucchi, Ousmane A. Koita
Publikováno v:
Malaria Journal, Vol 20, Iss 1, Pp 1-13 (2021)
Abstract Background The current first-line treatments for uncomplicated malaria recommended by the National Malaria Control Programme in Mali are artemether–lumefantrine (AL) and artesunate–amodiaquine (ASAQ). From 2015 to 2016, an in vivo study
Externí odkaz:
https://doaj.org/article/ce50d1a8576342ba839a66fb31f52bfd
Autor:
Alexandra M. Medley, Barbara J. Marston, Mitsuru Toda, Miwako Kobayashi, Michelle Weinberg, Leah F. Moriarty, M. Robynne Jungerman, Amethyst Clare A. Surpris, Barbara Knust, Anna M. Acosta, Caitlin E. Shockey, David Daigle, Zachary D. Schneider, Julia Charles, Atsuyoshi Ishizumi, Andrea Stewart, Laura A Vonnahme, Clive Brown, Stefanie White, Nicole J. Cohen, Marty Cetron
Publikováno v:
Emerging Infectious Diseases, Vol 27, Iss 3, Pp 710-718 (2021)
Public health travel restrictions (PHTR) are crucial measures during communicable disease outbreaks to prevent transmission during commercial airline travel and mitigate cross-border importation and spread. We evaluated PHTR implementation for US cit
Externí odkaz:
https://doaj.org/article/0e57ef58bf8b46f6ac258b0f67762e01